Introduction High‐flow nasal cannula (HFNC) is commonly used as first step respiratory
support in infants with moderate‐to‐severe acute viral bronchiolitis (AVB). This device …

Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …

High-flow nasal cannula (HFNC) is a relatively recent therapy that has been used to treat
respiratory failure. Until now, the criterion for failure requiring escalation to other forms of …

Purpose The high flow nasal cannula (HFNC) has recently been proposed to support infants
with respiratory syncytial virus (RSV)-related respiratory distress. However, in this disease …

Purpose High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line
respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min …

Objective To assess the inspiratory demand in young infants with acute viral bronchiolitis to
provide a physiological basis for initial flow setting for patients supported with high flow …

Introduction: Heated and humidified high flow nasal cannula oxygen therapy (HFNC) is
increasingly used to treat children with acute viral bronchiolitis. Aim: To determine whether …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …

The American Academy of Pediatrics (AAP) guidelines recommend only supportive therapy
for hospitalised infants with viral bronchiolitis. This includes oxygen therapy for hypoxaemia …

Aim Using a high‐flow nasal cannula (HFNC) for infant bronchiolitis is increasingly common,
but insufficiently studied. In this retrospective study, we examined the outcomes of HFNC …